Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing’s disease, a serious endocrine disorder

MPEG-4 Video

Right-click the button below for ‘SAVE’ options

Lisa Wollman, Cushing’s disease Patient
Annamaria Colao, MD and Rosario Pivonello, MD, Federico II University of Naples

Related Links

Novartis Oncology
Novartis

Related Documents

Signifor Fact Sheet
Cushing’s Disease Fact Sheet
US Press Release
Journalist Handbook: Special Focus on Cushing’s Disease